Cargando…

New Drugs and Novel Cellular Targets against Tuberculosis

Detalles Bibliográficos
Autores principales:	Degiacomi, Giulia, Makarov, Vadim, Pasca, Maria Rosalia, Chiarelli, Laurent Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693588/ https://www.ncbi.nlm.nih.gov/pubmed/36430162 http://dx.doi.org/10.3390/ijms232213680

Ejemplares similares

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2023)

Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019)

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
por: Salina, Elena G., et al.
Publicado: (2022)

Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
por: Mori, Giorgia, et al.
Publicado: (2020)

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
por: Degiacomi, Giulia, et al.
Publicado: (2020)

The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Editorial: New Approaches Against Drug-Resistant M. tuberculosis
por: Av-Gay, Yossef, et al.
Publicado: (2021)

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
por: Recchia, Deborah, et al.
Publicado: (2023)

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
por: Chiarelli, Laurent R., et al.
Publicado: (2018)

Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
por: Chiarelli, Laurent R., et al.
Publicado: (2020)

Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
por: Mori, Giorgia, et al.
Publicado: (2015)

Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer
por: Zhang, Yaqing, et al.
Publicado: (2023)

Targeting Unconventional T Cells for Vaccination against Tuberculosis
por: Wilkinson, Katalin A., et al.
Publicado: (2020)

Biochemical Characterization of Glutamate Racemase—A New Candidate Drug Target against Burkholderia cenocepacia Infections
por: Israyilova, Aygun, et al.
Publicado: (2016)

New approaches against the ancient pathogen Mycobacterium tuberculosis
por: EBioMedicine
Publicado: (2021)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
por: Stelitano, Giovanni, et al.
Publicado: (2020)

Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)
por: Egorova, Anna, et al.
Publicado: (2021)

The Fight against Tuberculosis in India: A New Weapon Needed
Publicado: (1945)

Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
por: Allison, Simon J.
Publicado: (2022)

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
por: de Jesus Lopes Ribeiro, Ana Luisa, et al.
Publicado: (2011)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

Against Pessimism in Tuberculosis
Publicado: (1950)

The Fight against Tuberculosis
Publicado: (1921)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

MicroRNAs - A New Generation Molecular Targets for Treating Cellular Diseases
por: Paulmurugan, Ramasamy
Publicado: (2013)

Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis
por: Lucarelli, Anna P., et al.
Publicado: (2010)

A new weapon against an old target
por: Fiehn, Christoph
Publicado: (2011)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
por: Tondi, Donatella
Publicado: (2021)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–2
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

New Sight: Enzymes as Targets for Drug Development
por: Kim, Sung-Kun
Publicado: (2023)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3
por: Mangoni, Arduino A., et al.
Publicado: (2018)

Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger
por: Salina, Elena G., et al.
Publicado: (2022)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–4
por: Mangoni, Arduino A, et al.
Publicado: (2018)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–5
por: Mangoni, Arduino A., et al.
Publicado: (2019)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
por: Vanden Eynde, Jean Jacques, et al.
Publicado: (2019)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
por: Gütschow, Michael, et al.
Publicado: (2020)

An insight into the role of dentists against the new epidemic of “Drug Abuse”
por: Hegde, Rahul
Publicado: (2016)

Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer
por: Tzakos, Andreas G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6c8228ach9kdqqma0h2fmorndl